Saw palmetto (Serenoa repens) is a native plant of North America and is most commonly found in Florida. Pygeum
(Prunus africanum) is an evergreen tree native to South Africa. Both berry raw material and extracts
of saw palmetto and pygeum are found in dietary supplements and are most commonly
used to treat symptoms related to benign prostatic hyperplasia (BPH) [1,2]. Saw palmetto
and pygeum are rich in fatty acids, and the fatty acid composition of both plants
is very similar. The goal of this study was to develop a gas chromatography – mass
spectroscopy (GC-MS) method that could be used to chemically distinguish the two species.
Briefly, 18 different dietary supplements containing either saw palmetto or pygeum
or saw palmetto and pygeum (purchased over-the-counter from different vendors) were
extracted in a liquid-liquid extraction using 10ml of methylene chloride. Prior to
analysis, each sample was derivatized and analyzed for fatty acid composition. The
major fatty acid components of saw palmetto are lauric acid (1), oleic acid (2), and myristic acid (3), and of pygeum are palmitic acid (4), linoleic acid (5), and oleic acid (2). Figures 1 & 2, demonstrate the chromatographic similarities and differences between
the saw palmetto, and the pygeum samples. The method proposed here is useful for chemical
fingerprint analysis and also for quality control of dietary supplements claiming
to contain pygeum or saw palmetto using GC-MS analysis.
Figure 1: TIC of Saw Palmetto using GC-MS analysis
Figure 2: TIC of Pygeum using GC-MS analysis
Acknowledgements: This research is supported in part by „Science Based Authentication of Dietary Supplements“
and „Botanical Dietary Supplement Research“ funded by the Food and Drug Administration
grant numbers 5U01FD002071–10 and 1U01FD003871–02, and the United States Department
of Agriculture, Agricultural Research Service, Specific Cooperative Agreement No.
58–6408–2-0009.
References: [1] Markowitz JS, Donovan JL, et al. (2003) Clin Pharmacol Ther, 74(6): 536–42.
[2] Quiles MT, et al. (2010) The Prostate, 70(10): 1044–1053.